Navigation Links
Essilor : First Half 2009 Results
Date:8/26/2009

es and in the scope of consolidation 15

Net debt increased by EUR99 million to EUR211 million, from EUR112 million at year-end 2008 as the Company' high profitability and robust performance enabled it to pursue an ambitious financial investment program involving acquisitions and share buybacks and to increase dividends. Net debt was also affected by the seasonal impact of annual discount payments to customers, which are generally concentrated in the first half. Net cash flow (cash flow less capital expenditure) rose by 12.5% to EUR99 million.

Related party transactions / Risks and contingencies

In first-half 2009, the nature of transactions with companies consolidated by the proportionate or equity method was not significantly different from the description in the 2008 Registration Document. Similarly, risks and contingencies to which the Company is exposed in the months ahead are generally in line with the analysis presented in Chapter 4 of the Registration Document.

Outlook

In the second half of the year, Essilor will continue to grow the business, leveraging the quality of its products and its services to opticians, backed by an acquisitions strategy that extends across all regions. The Company will also pursue its efforts to maintain a high operating margin. Over the full year, Essilor expects to strengthen its presence in all markets.

(1)Application of IFRS 8 - Operating Segments has resulted in the creation of the "Laboratory Equipment" business segment, which includes the machines, consumables and replacement parts sold by Satisloh and Delamare to prescription laboratories. The change has not has a material impact on revenue from the operating regions, which consolidate all of the other sales (primarily of ophthalmic lenses and optical instruments).

    ------------------------------

  
'/>"/>
SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Essilor - First-Half 2008 Revenue
9. Essilor Steps Up its Development in Eastern Europe
10. Essilor Agrees to Acquire Signet Armorlite
11. Essilor : 2008 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... New York personal injury attorney David Perecm... a personal injury attorney after a heavy metal pi...land backyard. , New York...al injury attorney David Perecman points to a rec...have the number of a personal injury attorney - ju...
(Date:11/24/2009)... Frozen Shoulder experts offer seminar series, ...-surgical relief to millions of sufferers. , ..., 2009 -- One-To-Zero (OTZ) Health Education Syste...ee 2010 Frozen Shoulder Syndrome Diagnosis & ...ing seminars begin at noon Friday and end at noon ...
(Date:11/24/2009)... Web content and Internet marketing specialists...ugh your website. , (PRWE...h year for the U.S. economy. Small business owners...o keep their businesses afloat and reduce costs. T... things like training or marketing programs that a...
(Date:11/24/2009)....24/PRNewswire/--MinuteClinic,thepioneerandlargest...hasopeneditsfirstretailhealthcarecenterinWashingto...eclinicisopensevendaysaweekandwillservepatientsinN...ston,KingmanPark,AtlasDistrict,IvyCityandtheGallau...ylocatedstore-basedclinic,weareexpandingaccesstohi...
(Date:11/24/2009)...C.,Nov.24/PRNewswire/--TheAmericanSocietyofEchocar...yabouttheimpactofthe2010CMSPhysicianFeeSchedule(PF...dcardiovascularultrasoundtechnicianssurveyed,87per...tingMedicarepatients,reducestafforshutdowntheirpra...echocardiography(heartultrasound)andothervitalserv...
Breaking Medicine News(10 mins):Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2
...response to increased demand for halide compounds,...d the capacity for U.S. based manufacturing of met... Los Angeles, CA (PRWEB) August 22, 20...ng of metallic iodide and bromide compounds., , , ...
...sup executive Paul Gada outlines key financial con...eople with degenerative diseases during National Y...ta. , Belleville, Ill. (V...sons-Disease.aspx [Parkinson,s disease] raises ob...
...nology Integrated with the Award Winning ..., Ala., Aug. 21 CytoViva Inc., a leading provider...gy research market, has,integrated new hyperspectr...dvances in a wide range of nano-medicine,and nano-...
...re Unit to Provide Patients Cleveland Clinic ...EVELAND, Aug. 21 Cleveland Clinic has launched a,...specialized care by,Cleveland Clinic physicians, n...ing jets., With the launch of this program, Cleve...
...Bodaken,Chairman, President & CEO of Blue Shield o... 2008 Rocky Mountain Roundtable on Health, Wellnes...tional Convention on Monday,August 25, 2008, 9:30 ...he ways in which health plans work with employers,...
...., Aug. 21 Fairview and,Blue Cross and Blue Shiel...ract that allows Fairview clinics to remain as par...r networks. The Fairview clinic contract was,set t...th the Blue Cross network. The hospital contract w...
Other Medicine News:Health News:Five Steps for Staying in Financial Control with Long-Term Disability 2Health News:Five Steps for Staying in Financial Control with Long-Term Disability 3Health News:Five Steps for Staying in Financial Control with Long-Term Disability 4Health News:CytoViva(R) Introduces Breakthrough Nano-Technology Research Tool 2Health News:Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program 2Health News:Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program 3Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2
(Date:11/24/2009)...v.24/PRNewswire/--AFOXThanksgivingDaytelevisionspe....S.remindsviewersthattheholidaysareatimetobegratef...rallthosewhofightthatbattleeachdayassurvivors,care...hehistoricreturntotheiceofcancersurvivorsScottHami...on-JohnandDavidFosterwhowillperform"HopeisAlwaysHe...
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/--FebeDurango-Rueda,...oparticipatinginaschemetodefraudtheExport-ImportBa...announcedAssistantAttorneyGeneraloftheCriminalDivi....GratacosoftheEx-ImBank,OfficeoftheInspectorGenera...obertsinU.S.DistrictCourtinWashingtontoaone-countc...
(Date:11/23/2009)...a.,Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasd...ment-reagentsystemstothebloodtransfusionindustry,t...Jaffray21stAnnualHealthCareConferenceinNewYork,NYw...TheCompany,spresentationisscheduledforTuesday,Dece...ntationwillbeavailablethroughthe"AboutUs--Investor...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia 12813 1Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia 12813 2Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia 12813 3Video 3A New Online Film Introduces Longevinex Advantage 28TM 29 The First Resveratrol Based Dietary Supplement to Address Both Cellular and Connec 50244 1Video 3A New Online Film Introduces Longevinex Advantage 28TM 29 The First Resveratrol Based Dietary Supplement to Address Both Cellular and Connec 50244 2Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 1Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 2Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 3
...SAN MATEO, Calif., Oct. 3 Anthera Pharmaceuticals...developing,anti-inflammatory therapeutics for chro...y the completion of enrollment and patient dosing ...d, A-002 for stable coronary,artery disease. Data ...f,the year. "We are pleased with the rapid enroll...
...NEW YORK, Oct. 2 ImClone Systems Incorporated,(Na...SE: BMY ) today announced,that the U.S. Food and ...o,the ERBITUX(R) (Cetuximab) product labeling to i...epidermal growth factor inhibitor,(EGFR)-expressin...er,failure of both irinotecan- and oxaliplatin-bas...
Other Medicine Technology:Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 2Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7
TPS-TL Spinal Spacer
...esorbable, osteoconductive matrix consisting of hy...ared for use in oral maxillofacial procedures as a...g Pro Osteon 200R has been FDA indicated as a bone...h bone during the healing process. Its interconnec...
O-arm Complete Multidimensional Surgical Imaging
Merlin Patient Care System
Medicine Products: